Gyre Therapeutics, Inc. (GYRE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 630.77M |
| Enterprise Value | 594.64M |
| P/E Ratio | -86.87 |
| PEG Ratio | 0.41 |
| Price/Sales Ratio | 5.01 |
| Price/Book Ratio | 5.79 |
| Enterprise/Revenue | 4.7 |
| Enterprise/EBITDA | 174.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.05 |
| Operating Margin | -0 |
| Return On Assets | -0.04 |
| Return On Equity | -0.06 |
| Revenue | 116.59M |
| Revenue/Share | 1.28 |
| Gross Profit | 111.17M |
| EBITDA | 16.96M |
| Net Income | 5.03M |
| Diluted EPS | 0.02 |
| Total Cash | 49.81M |
| Total Cash/Share | 0.55 |
| Total Debt | 823,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.64 |
| Book Value Per Share | 1.5 |
| 52-Week Change | -13.13 |
| 52-Week High | 9.42 |
| 52-Week Low | 5.44 |
| Moving Average 50 Days | 6.44 |
| Moving Average 200 Days | 7.4 |
| Average Volume | 94,593 |
| Shares Outstanding | 91.39M |
| % Held by Institutions | 3.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | October 31, 2023 |